In 2001, Vertex Pharmaceuticals Incorporated acquired San Diego-based biotech company, Aurora Biosciences. Would improve the combination of vertex and Aurora technologies the flow of novel drug candidates in development. However, some questions were related to the integration of Aurora vertex still unresolved, the most urgent Aurora is important collaboration with the Cystic Fibrosis Foundation (CFF). Venture Philanthropy Foundation and has been adequate funding mech … Read more »

In 2001, Vertex Pharmaceuticals Incorporated acquired San Diego-based biotech company, Aurora Biosciences. Would improve the combination of vertex and Aurora technologies the flow of novel drug candidates in development. However, some questions were related to the integration of Aurora vertex still unresolved, the most urgent Aurora is important collaboration with the Cystic Fibrosis Foundation (CFF). Venture Philanthropy Foundation and has been an appropriate mechanism to fund a public company, such as vertex? How could the board of the vertex and the CFF fundamentally align the goals of a for-profit company with which a non-profit organization? These were the questions that leaders of the vertex.
«Hide

from
Robert F. Higgins,
Brent Kazan
Source: Harvard Business School
27 pages.
Publication Date: Oct 15, 2007. Prod #: 808005-PDF-ENG
Vertex Pharmaceuticals and the Cystic Fibrosis Foundation: Venture Philanthropy Funding for biotech HBR case solution